2023
DOI: 10.1016/j.jacc.2023.02.050
|View full text |Cite
|
Sign up to set email alerts
|

Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(11 citation statements)
references
References 46 publications
0
4
0
Order By: Relevance
“…high-sensitivity C-Reactive Protein). 16 21 It may well be that dietary fats alone are an insufficient driver of Lp(a)'s atherogenic inducing mechanisms (including via elevated high sensitivity C-Reactive Protein or OxPL). Future studies may require evaluating additional macronutrients, more complex dietary patterns, and additional biomarkers to understand diet's association between Lp(a) and CV disease.…”
Section: Discussionmentioning
confidence: 99%
“…high-sensitivity C-Reactive Protein). 16 21 It may well be that dietary fats alone are an insufficient driver of Lp(a)'s atherogenic inducing mechanisms (including via elevated high sensitivity C-Reactive Protein or OxPL). Future studies may require evaluating additional macronutrients, more complex dietary patterns, and additional biomarkers to understand diet's association between Lp(a) and CV disease.…”
Section: Discussionmentioning
confidence: 99%
“…The net result indicated that each apoB particle was proatherogenic [ 24 ]. Furthermore, phospholipids, one of the components of apoB particles, were strong proatherogenic factors associated with poor prognosis in an oxidized state [ 25 ]. Thus, compared to LDL-C, apoB particles integrated more proatherogenic risk factors in most cases.…”
Section: Discussionmentioning
confidence: 99%
“…Growing evidence illustrated the importance of apoB in the prevalence of CAD [ 25 , 27 ]; however, its predictive efficacy for CAD progression remained unclear. Richardson et al performed a genome-wide association study of LDL-C, apoB, and TG in the UK Biobank and validated the associations using a second database, CARDIoGRAMplusC4D.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have shown that Lp(a) as a risk factor for CAD is more pronounced in patients with high-density lipoprotein cholesterol (HDL-C) ≥35 mg/dL and non-obese patients [ 11 ]. Lp(a) and oxidized phospholipids apoB (OxPL-apoB) are associated with multiple coronary artery lesions, and Lp(a), OxPL-apoB, and OxPL-apo(a) are associated with cardiovascular events [ 13 ].…”
Section: Introductionmentioning
confidence: 99%